Contract Award
No summary for this filing – the full text is below.
Select text to share a quote on X · sign in to keep highlights & notes in your PYC notes
Physiomics plc (AIM: PYC), a leading mathematical modelling and data science company supporting the development of new therapeutics and personalised medicine solutions, is pleased to announce that it has been awarded a substantial new contract by an existing large pharma client. The project involves Pharmacokinetic-Pharmacodynamic (PKPD) modelling in the field of DNA damage/ repair field and will help inform clinical dose and scheduling decisions. The value of the project is £178k and it is anticipated that it will be completed over the course of the next six months.
Dr Peter Sargent, CEO, commented: "We are very pleased that we've been awarded this substantial project and we very much look forward to working with the client team on this exciting project".
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.